121 related articles for article (PubMed ID: 16315914)
41. Clinical implications of peritoneal cytology in potentially resectable pancreatic cancer: positive peritoneal cytology may not confer an adverse prognosis.
Yamada S; Takeda S; Fujii T; Nomoto S; Kanazumi N; Sugimoto H; Kasuya H; Kodera Y; Nagasaka T; Morita S; Nakao A
Ann Surg; 2007 Aug; 246(2):254-8. PubMed ID: 17667504
[TBL] [Abstract][Full Text] [Related]
42. Analysis of prognostic factors in seventy patients having a complete cytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancer.
da Silva RG; Sugarbaker PH
J Am Coll Surg; 2006 Dec; 203(6):878-86. PubMed ID: 17116556
[TBL] [Abstract][Full Text] [Related]
43. Pathologic determinants of survival after resection of T3N0 (Stage IIA) colorectal cancer: proposal for a new prognostic model.
Cianchi F; Messerini L; Comin CE; Boddi V; Perna F; Perigli G; Cortesini C
Dis Colon Rectum; 2007 Sep; 50(9):1332-41. PubMed ID: 17429709
[TBL] [Abstract][Full Text] [Related]
44. T cell infiltrate predicts long-term survival following resection of colorectal cancer liver metastases.
Katz SC; Pillarisetty V; Bamboat ZM; Shia J; Hedvat C; Gonen M; Jarnagin W; Fong Y; Blumgart L; D'Angelica M; DeMatteo RP
Ann Surg Oncol; 2009 Sep; 16(9):2524-30. PubMed ID: 19568816
[TBL] [Abstract][Full Text] [Related]
45. Long-term prognostic value of detection of circulating colorectal cancer cells using CGM2 reverse transcriptase-polymerase chain reaction assay.
Douard R; Wind P; Sales JP; Landi B; Berger A; Benichou J; Gayral F; Loric S; Cugnenc PH
Surgery; 2006 Apr; 139(4):556-62. PubMed ID: 16627067
[TBL] [Abstract][Full Text] [Related]
46. The second procedure combining complete cytoreductive surgery and intraperitoneal chemotherapy for isolated peritoneal recurrence: postoperative course and long-term outcome.
Brouquet A; Goéré D; Lefèvre JH; Bonnet S; Dumont F; Raynard B; Elias D
Ann Surg Oncol; 2009 Oct; 16(10):2744-51. PubMed ID: 19626375
[TBL] [Abstract][Full Text] [Related]
47. Prognostic value of CEA and CA 19-9 tumor markers combined with cytology from peritoneal fluid in colorectal cancer.
Lee IK; Kim DH; Gorden DL; Lee YS; Sung NY; Park GS; Kim HJ; Kang WK; Park JK; Ahn CH; Kim JG; Jeon HM; Oh ST
Ann Surg Oncol; 2009 Apr; 16(4):861-70. PubMed ID: 19189191
[TBL] [Abstract][Full Text] [Related]
48. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
[TBL] [Abstract][Full Text] [Related]
49. Liver resection for metastatic colorectal cancer in patients with concurrent extrahepatic disease: results in 127 patients treated at a single center.
Carpizo DR; Are C; Jarnagin W; Dematteo R; Fong Y; Gönen M; Blumgart L; D'Angelica M
Ann Surg Oncol; 2009 Aug; 16(8):2138-46. PubMed ID: 19495884
[TBL] [Abstract][Full Text] [Related]
50. [The treatment strategy for type 4 gastric cancer with positive lavage cytology--a decision making of the therapeutic strategy by the change of the result of the lavage cytology].
Nunobe S; Iwasaki Y; Ohashi M; Shirou I; Takahashi K; Yamaguchi T; Matsumoto H; Yasutome M
Gan To Kagaku Ryoho; 2007 Nov; 34(12):1952-4. PubMed ID: 18219862
[TBL] [Abstract][Full Text] [Related]
51. 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer.
Verwaal VJ; Bruin S; Boot H; van Slooten G; van Tinteren H
Ann Surg Oncol; 2008 Sep; 15(9):2426-32. PubMed ID: 18521686
[TBL] [Abstract][Full Text] [Related]
52. Clinical significance of microvessel count in patients with metastatic liver cancer originating from colorectal carcinoma.
Nanashima A; Shibata K; Nakayama T; Tobinaga S; Araki M; Kunizaki M; Takeshita H; Hidaka S; Sawai T; Nagayasu T; Yasutake T
Ann Surg Oncol; 2009 Aug; 16(8):2130-7. PubMed ID: 19495885
[TBL] [Abstract][Full Text] [Related]
53. Survival after hepatic resection in metastatic colorectal cancer: a population-based study.
Cummings LC; Payes JD; Cooper GS
Cancer; 2007 Feb; 109(4):718-26. PubMed ID: 17238180
[TBL] [Abstract][Full Text] [Related]
54. Intrahepatic lymphatic invasion independently predicts poor survival and recurrences after hepatectomy in patients with colorectal carcinoma liver metastases.
Korita PV; Wakai T; Shirai Y; Sakata J; Takizawa K; Cruz PV; Ajioka Y; Hatakeyama K
Ann Surg Oncol; 2007 Dec; 14(12):3472-80. PubMed ID: 17828431
[TBL] [Abstract][Full Text] [Related]
55. Influence of surgical margin on type of recurrence after liver resection for colorectal metastases: a single-center experience.
Nuzzo G; Giuliante F; Ardito F; Vellone M; Giovannini I; Federico B; Vecchio FM
Surgery; 2008 Mar; 143(3):384-93. PubMed ID: 18291260
[TBL] [Abstract][Full Text] [Related]
56. [Clinical effect of intraoperative peritoneal hyperthermic chemotherapy for advanced gastric cancer].
Zhu ZG; Tang R; Yan M; Chen J; Yang QM; Li S; Yao XX; Zhang J; Yin HR; Lin YZ
Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Jan; 9(1):26-30. PubMed ID: 16437366
[TBL] [Abstract][Full Text] [Related]
57. Can intra-operative intraperitoneal free cancer cell detection techniques identify patients at higher recurrence risk following curative colorectal cancer resection: a meta-analysis.
Rekhraj S; Aziz O; Prabhudesai S; Zacharakis E; Mohr F; Athanasiou T; Darzi A; Ziprin P
Ann Surg Oncol; 2008 Jan; 15(1):60-8. PubMed ID: 17909914
[TBL] [Abstract][Full Text] [Related]
58. How many lymph nodes should be examined in Dukes' B colorectal cancer? Determination on the basis of cumulative survival rate.
Yoshimatsu K; Ishibashi K; Umehara A; Yokomizo H; Yoshida K; Fujimoto T; Watanabe K; Ogawa K
Hepatogastroenterology; 2005; 52(66):1703-6. PubMed ID: 16334761
[TBL] [Abstract][Full Text] [Related]
59. [Surgical outcomes and prognostic factors of primary colorectal cancer with peritoneal dissemination].
Takahashi S; Yoshida E; Morohashi H; Sakamoto Y; Koyama M; Murata A; Hakamada K
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2044-6. PubMed ID: 24394007
[TBL] [Abstract][Full Text] [Related]
60. Preoperative plasma vascular endothelial growth factor but not nitrite is a useful complementary tumor marker in patients with colorectal cancer.
Tsai WS; Changchien CR; Yeh CY; Chen JS; Tang R; Chiang JM; Hsieh PS; Fan CW; Wang JY
Dis Colon Rectum; 2006 Jun; 49(6):883-94. PubMed ID: 16741643
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
